STAT

Opinion: Biohackers are about open-access to science, not DIY pandemics. Stop misrepresenting us

Hey, @nytimes, biohackers working in community labs aren't "on the path to a D.I.Y. pandemic." We're a resource for good, not bad.

Some people call me a biohacker. My colleagues like the term because it sounds cool, and journalists like it because it gets clicks. I prefer being called a community biologist, do-it-yourself biologist, or even a citizen scientist, terms that are all interchangeable with biohacker.

The New York Times recently warning the public about biohackers who are , a bioengineering tool that lets researchers make tiny and specific edits to DNA. The article assembled a number of news items — which included a biotech executive pricking himself with a homemade herpes treatment, scientists at University of Alberta in Edmonton synthesizing cowpox, and work at my community lab

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks